Attached files

file filename
8-K - FORM 8-K - CAREFUSION Corpd8k.htm
EX-99.3 - INFORMATION DISCLOSED BY CAREFUSION CORPORATION - CAREFUSION Corpdex993.htm
EX-99.1 - NEWS RELEASE ISSUED BY CAREFUSION CORPORATION - CAREFUSION Corpdex991.htm
©
2010 CareFusion Corporation or one of its subsidiaries. All rights reserved.
February 9, 2010
Q2 and 1H Fiscal 2010
Investor/Analyst Call
Exhibit 99.2


©
2010 CareFusion Corporation or one of its subsidiaries. All rights reserved.
2
Forward-Looking Statements and
GAAP Reconciliation
Forward-Looking Statements and
GAAP Reconciliation
contains forward-looking statements addressing expectations, prospects, estimates and other matters that are
dependent upon future events or developments.  The matters discussed in these forward-looking statements are
subject to risks and uncertainties that could cause actual results to differ materially from those projected, anticipated
or implied.  The most significant of these uncertainties are described in CareFusion’s Form 10-K, Form 10-Q and
Form 8-K reports (including all amendments to those reports) and exhibits to those reports, and
include (but are not limited to) the following: we may be unable to effectively enhance our existing products or
introduce and market new products or may fail to keep pace with advances in technology; we are subject to complex
and costly regulation; cost containment efforts of our customers, purchasing groups, third-party payers and
governmental organizations could adversely affect our sales and profitability; declining economic conditions could
adversely affect our results of operations and financial condition; we may be unable to protect our
intellectual property rights or may infringe on the intellectual property rights of others; defects or failures associated
with our products and/or our quality system could lead to the filing of adverse event reports, recalls or safety alerts
and negative publicity and could subject us to regulatory actions; we are currently operating under a consent decree
with the FDA and our failure to comply with the requirements of the consent decree may have an adverse effect on
our business; and we may face significant uncertainty in the industry due to government healthcare reform.  This
presentation reflects management’s views as of February 9, 2010. Except to the extent required by applicable law,
we undertake no obligation to update or revise any forward-looking statement. 
measures. Reconciliations can be found on slide 14 of this presentation.  In addition, definitions and 
reconciling
information
can
be
found
on
CareFusion’s
website
at
www.carefusion.com
under
the
SEC
Filings
link
of
the
Investor
Relations
tab.
“Safe
Harbor”
Statement
under
the
Private
Securities
Litigation
Reform
Act
of
1995:
This
presentation
Non-GAAP
Financial
Measures:
The
financial
information
included
in
this
presentation
includes
Non-GAAP financial


©
2010 CareFusion Corporation or one of its subsidiaries. All rights reserved.
3
Today’s Speakers
Today’s Speakers
Dave Schlotterbeck, Chairman and Chief Executive Officer
Ed Borkowski, Chief Financial Officer


©
2010 CareFusion Corporation or one of its subsidiaries. All rights reserved.
Q2 and 1H Fiscal 2010 Results
Q2 and 1H Fiscal 2010 Results
©
2010 CareFusion Corporation or one of its subsidiaries. All rights reserved.


©
2010 CareFusion Corporation or one of its subsidiaries. All rights reserved.
3
3
2
Q2 Fiscal 2010 Year-Over-Year
Quarterly Review
Q2 Fiscal 2010 Year-Over-Year
Quarterly Review
11%
$329
16%
$351
Operating Expenses
%
Change
$M
%
Change
$M
$0.33
$73
$127
$1,019
GAAP
(37)%
(32)%
(26)%
5%
(20)%
$88
Income From Continuing
Operations
(21)%
$0.39
Diluted EPS From Continuing
Operations
Adjusted
Revenue
$1,019
5%
Operating
Income
$149
(15)%
5
% Change over prior year period.
2
Adjusted operating income and adjusted operating expenses are Non-GAAP financial measures that exclude nonrecurring items related to
restructuring and acquisition integration charges and nonrecurring spinoff related costs.
3
Adjusted income from continuing operations and adjusted diluted earnings per share are Non-GAAP financial measures that exclude nonrecurring
items related to restructuring and acquisition integration charges, nonrecurring spinoff related costs and nonrecurring tax items.
1
2
1


©
2010 CareFusion Corporation or one of its subsidiaries. All rights reserved.
15%
$337
15%
$337
Revenues
(19)%
(39)%
$M
$111
$682
$M
GAAP
$16
%
Change
(24)%
1%
%
Change
%
Change
$M
Critical Care Technologies
%
Change
$M
Medical Technologies and
Services
$23
Segment Profit
Adjusted
Revenues
$682
1%
Segment Profit
$126
(15)%
6
Q2 Fiscal 2010 Year-Over-Year
Quarterly Segment Review
Q2 Fiscal 2010 Year-Over-Year
Quarterly Segment Review
2
2
1
1
1
1
1
  % Change over prior year period.
2
  Adjusted segment profit is a Non-GAAP financial measure that excludes nonrecurring items related to restructuring and acquisition integration
   charges and nonrecurring spinoff related costs.


©
2010 CareFusion Corporation or one of its subsidiaries. All rights reserved.
3
2
2
3
Q2 Fiscal 2010 Sequential
Quarterly Review
Q2 Fiscal 2010 Sequential
Quarterly Review
3%
$329
5%
$351
Operating Expenses
%
Change
$M
%
Change
$M
$0.33
$73
$127
$1,019
GAAP
32%
32%
9%
11%
1%
$88
Income From Continuing
Operations
0%
$0.39
Diluted EPS From Continuing
Operations
Adjusted
Revenue
$1,019
11%
Operating Income
$149
12%
7
% Change over Q1 Fiscal 2010.
2
Adjusted operating income and adjusted operating expenses are Non-GAAP financial measures that exclude nonrecurring items related to
restructuring and acquisition integration charges and nonrecurring spinoff related costs.
3
Adjusted income from continuing operations and adjusted diluted earnings per share are Non-GAAP financial measures that exclude nonrecurring
items related to restructuring and acquisition integration charges, nonrecurring spinoff related costs and nonrecurring tax items.
1
1


©
2010 CareFusion Corporation or one of its subsidiaries. All rights reserved.
2
2
10%
$337
10%
$337
Revenues
6%
(2)%
$M
$111
$682
$M
GAAP
$16
%
Change
11%
11%
%
Change
%
Change
$M
Critical Care Technologies
%
Change
$M
Medical Technologies and
Services
$23
Segment Profit
Adjusted
Revenues
$682
11%
Segment Profit
$126
13%
8
Q2 Fiscal 2010 Sequential
Quarterly Segment Review
Q2 Fiscal 2010 Sequential
Quarterly Segment Review
1
1
1
1
1
  % Change over Q1 Fiscal 2010.
2
  Adjusted segment profit is a Non-GAAP financial measure that excludes nonrecurring items related to restructuring and acquisition integration
   charges and nonrecurring spinoff related costs.


©
2010 CareFusion Corporation or one of its subsidiaries. All rights reserved.
1H Fiscal 2010 Review
1H Fiscal 2010 Review
5%
$646
6%
$685
Operating Expenses
%
Change
$M
%
Change
$M
$0.58
$128
$244
$1,942
GAAP
(11)%
(7)%
(7)%
3%
8%
$174
Income From Continuing
Operations
8%
$0.79
Diluted EPS From Continuing
Operations
Adjusted
Revenue
$1,942
3%
Operating Income
$283
(5)%
9
% Change over prior year period.
2
Adjusted operating income and adjusted operating expenses are Non-GAAP financial measures that exclude nonrecurring items related to
restructuring and acquisition integration charges and nonrecurring spinoff related costs.
3
Adjusted income from continuing operations and adjusted diluted earnings per share are Non-GAAP financial measures that exclude nonrecurring
items related to restructuring and acquisition integration charges, nonrecurring spinoff related costs and nonrecurring tax items.
1
1
2
2
3
3


©
2010 CareFusion Corporation or one of its subsidiaries. All rights reserved.
1H Fiscal 2010 Segment Review
1H Fiscal 2010 Segment Review
9%
$643
9%
$643
Revenues
(14)%
(22)%
$M
$212
$1,299
$M
GAAP
$32
%
Change
(4)%
0%
%
Change
%
Change
$M
Critical Care Technologies
%
Change
$M
Medical Technologies and
Services
$46
Segment
Profit
Adjusted
Revenues
$ 1,299
0%
Segment
Profit
$238
(3)%
10
1
2
1
1
2
1
1
  % Change over prior year period.
2
  Adjusted segment profit is a Non-GAAP financial measure that excludes nonrecurring items related to restructuring and acquisition integration 
    charges and nonrecurring spinoff related costs.


©
2010 CareFusion Corporation or one of its subsidiaries. All rights reserved.
Fiscal 2010 Guidance
Fiscal 2010 Guidance
©
2010 CareFusion Corporation or one of its subsidiaries. All rights reserved.


©
2010 CareFusion Corporation or one of its subsidiaries. All rights reserved.
$3,850 -
$4,000
$3,950 -
$4,050
Total Revenue
~47 -
48%
~48%
Gross Margin
35% of total revenue
34 -
35% of total revenue
Adjusted Operating Expenses
~25 -
26%
~28%
Adjusted
Tax
Rate
~$120 -130
~$120 -
$130
Nonrecurring Items
$1.35 -
$1.45
$1.40 -
$1.45
Adjusted
Diluted
EPS
~221
~223
Diluted Weighted Average
Shares Outstanding
$180
$160 -
$170
Capital Expenditures
Updated
FY10 Outlook
$ in millions
Previous
FY10
Outlook
12
Revised Fiscal 2010
Financial Guidance
Revised Fiscal 2010
Financial Guidance
2
3
3
4
1
1
Provided by CareFusion on November 5, 2009.
2
Adjusted operating expenses is a Non-GAAP financial measure that excludes nonrecurring items related to restructuring and acquisition integration 
charges and nonrecurring spinoff related costs.
3
Adjusted tax rate and adjusted diluted earnings per share are Non-GAAP financial measures that exclude nonrecurring items related to restructuring and
acquisition integration charges, nonrecurring spinoff related costs, nonrecurring tax items and discontinued operations.
4
Nonrecurring items are related to restructuring and acquisition integration charges, nonrecurring spinoff related costs and nonrecurring tax items.


Q&A
Q&A
©
2010 CareFusion Corporation or one of its subsidiaries. All rights reserved.


©
2010 CareFusion Corporation or one of its subsidiaries. All rights reserved.
www.carefusion.com    
under the SEC Filings link of the Investor
Non-GAAP Reconciliations
Non-GAAP Reconciliations
$88
$15
$73
Income From Continuing
Operations
$0.39
$0.07
$0.33
Diluted EPS From Continuing
Operations
$329
$(22)
$351
Operating Expenses
$149
$22
$127
Operating Income
FY10 Q2
GAAP
$M
Nonrecurring
Items
$M
FY10 Q2
Adjusted
$M
Critical Care Technologies
Segment Profit
$111
$15
$126
Medical Technologies and Services
Segment Profit
$16
$7
$23
14
2
1
1  
Nonrecurring items are related to restructuring and acquisition integration charges, nonrecurring spinoff related costs and nonrecurring tax items.
2
Earnings per share calculations are performed for each column presented. Therefore, the sum of the per share adjustments from the table above may
not equal the adjusted per share total presented.
Note: A full GAAP to non-GAAP reconciliation can be found on CareFusion’s website at                                         
Relations tab. A discussion of the reasons why management believes that the presentation of non-GAAP financial measures provides useful information to
investors regarding the company’s financial condition and results of operations is included in Exhibit 99.3 of Form 8-K filed by the company on February 9, 2010.